JP2010522141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010522141A5 JP2010522141A5 JP2009546461A JP2009546461A JP2010522141A5 JP 2010522141 A5 JP2010522141 A5 JP 2010522141A5 JP 2009546461 A JP2009546461 A JP 2009546461A JP 2009546461 A JP2009546461 A JP 2009546461A JP 2010522141 A5 JP2010522141 A5 JP 2010522141A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- seq
- chain variable
- variable region
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88543907P | 2007-01-18 | 2007-01-18 | |
| US60/885,439 | 2007-01-18 | ||
| PCT/US2008/050554 WO2008088983A1 (en) | 2007-01-18 | 2008-01-09 | PEGYLATED Aβ FAB |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013133551A Division JP5782479B2 (ja) | 2007-01-18 | 2013-06-26 | ＰＥＧ化ＡβＦＡＢ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010522141A JP2010522141A (ja) | 2010-07-01 |
| JP2010522141A5 true JP2010522141A5 (enExample) | 2011-02-10 |
| JP5307030B2 JP5307030B2 (ja) | 2013-10-02 |
Family
ID=39332186
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546461A Expired - Fee Related JP5307030B2 (ja) | 2007-01-18 | 2008-01-09 | ＰＥＧ化ＡβＦＡＢ |
| JP2013133551A Expired - Fee Related JP5782479B2 (ja) | 2007-01-18 | 2013-06-26 | ＰＥＧ化ＡβＦＡＢ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013133551A Expired - Fee Related JP5782479B2 (ja) | 2007-01-18 | 2013-06-26 | ＰＥＧ化ＡβＦＡＢ |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8066999B2 (enExample) |
| EP (2) | EP2121754B1 (enExample) |
| JP (2) | JP5307030B2 (enExample) |
| KR (2) | KR101160385B1 (enExample) |
| CN (2) | CN103479998B (enExample) |
| AR (1) | AR064944A1 (enExample) |
| AU (1) | AU2008206555B2 (enExample) |
| BR (1) | BRPI0806715A2 (enExample) |
| CA (1) | CA2675847C (enExample) |
| CL (1) | CL2008000121A1 (enExample) |
| CY (2) | CY1116157T1 (enExample) |
| DK (1) | DK2121754T3 (enExample) |
| EA (1) | EA020979B1 (enExample) |
| ES (2) | ES2535641T3 (enExample) |
| HR (2) | HRP20150237T1 (enExample) |
| IL (2) | IL199838A (enExample) |
| LT (1) | LT2842967T (enExample) |
| MX (1) | MX2009007691A (enExample) |
| PE (1) | PE20081634A1 (enExample) |
| PL (1) | PL2121754T3 (enExample) |
| PT (2) | PT2842967T (enExample) |
| RS (1) | RS53948B1 (enExample) |
| SI (2) | SI2842967T1 (enExample) |
| TW (1) | TW200836763A (enExample) |
| UA (1) | UA95996C2 (enExample) |
| WO (1) | WO2008088983A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110257104A1 (en) | 2008-06-20 | 2011-10-20 | Massachusetts Institute Of Technology | Methods to identify macromolecule binding and aggregation prone regions in proteins and uses therefor |
| KR20170116193A (ko) | 2008-06-20 | 2017-10-18 | 노파르티스 아게 | 응집이 감소된 면역글로불린 |
| KR101861295B1 (ko) * | 2009-06-04 | 2018-05-25 | 노파르티스 아게 | ＩｇＧ 콘쥬게이션을 위한 자리의 확인 방법 |
| EA201201227A1 (ru) | 2010-03-03 | 2013-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Бипаратопные а-бета-связывающие полипептиды |
| JP6231263B2 (ja) * | 2012-07-17 | 2017-11-15 | 株式会社島津製作所 | アフィニティ支持体及びそれを用いた物質の捕捉方法 |
| US10431325B2 (en) | 2012-08-03 | 2019-10-01 | Novartis Ag | Methods to identify amino acid residues involved in macromolecular binding and uses therefor |
| WO2015036553A1 (en) * | 2013-09-16 | 2015-03-19 | Novo Nordisk Health Care Ag | Thiol functionalized polymers |
| KR20150133576A (ko) | 2014-05-20 | 2015-11-30 | 삼성전자주식회사 | 화학적 개질된 표적화 단백질 및 그의 이용 |
| AU2016354688B2 (en) | 2015-11-09 | 2021-12-16 | The University Of British Columbia | Epitopes in Amyloid beta mid-region and conformationally-selective antibodies thereto |
| HK1259324A1 (zh) | 2015-11-09 | 2019-11-29 | 英属哥伦比亚大学 | 淀粉样蛋白β表位及其抗体 |
| EP3374379A4 (en) | 2015-11-09 | 2019-05-15 | The University Of British Columbia | N-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATION-SELECTIVE ANTIBODIES |
| TWI735600B (zh) | 2016-07-01 | 2021-08-11 | 美商美國禮來大藥廠 | 抗－N3pGlu類澱粉β肽抗體及其用途 |
| KR102550991B1 (ko) | 2016-07-18 | 2023-07-04 | 더 유니버시티 오브 브리티쉬 콜롬비아 | 아밀로이드 베타에 대한 항체 |
| WO2018031361A2 (en) | 2016-08-09 | 2018-02-15 | Eli Lilly And Company | Combination therapy |
| US20180125920A1 (en) | 2016-11-09 | 2018-05-10 | The University Of British Columbia | Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions |
| US12286469B2 (en) | 2017-07-18 | 2025-04-29 | The University Of British Columbia | Humanized antibodies binding to amyloid-beta (A-beta) |
| WO2019014768A1 (en) | 2017-07-18 | 2019-01-24 | The University Of British Columbia | ANTI-BETA-AMYLOID ANTIBODY |
| JP7368856B2 (ja) | 2017-07-25 | 2023-10-25 | トゥルーバインディング，インコーポレイテッド | Ｔｉｍ－３とそのリガンドとの相互作用の遮断によるがん治療 |
| US20210140980A1 (en) * | 2018-01-04 | 2021-05-13 | Septa Therapeutics, Inc. | Septapeptides associated with neurodegeneracy |
| CN116063505B (zh) | 2019-01-30 | 2024-05-03 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| US12281166B2 (en) | 2020-05-26 | 2025-04-22 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking Galectin-3 |
| TW202300518A (zh) | 2021-03-12 | 2023-01-01 | 美商美國禮來大藥廠 | 抗N3pGlu類澱粉β抗體及其用途 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5278049A (en) | 1986-06-03 | 1994-01-11 | Incyte Pharmaceuticals, Inc. | Recombinant molecule encoding human protease nexin |
| US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5753624A (en) | 1990-04-27 | 1998-05-19 | Milkhaus Laboratory, Inc. | Materials and methods for treatment of plaquing disease |
| US5445090A (en) | 1991-07-25 | 1995-08-29 | Mim Industries, Inc. | Interchangeable clamp for use in a sewing machine |
| US5766846A (en) | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| US5837672A (en) | 1992-07-10 | 1998-11-17 | Athena Neurosciences, Inc. | Methods and compositions for the detection of soluble β-amyloid peptide |
| CA2115900A1 (en) | 1993-02-22 | 1994-08-23 | Gerald W. Becker | Pharmaceutical screens and antibodies |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| AU692237B2 (en) | 1994-02-03 | 1998-06-04 | Picower Institute For Medical Research, The | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
| US5668651A (en) * | 1994-03-18 | 1997-09-16 | Sharp Kabushiki Kaisha | Polymer-wall LCD having liquid crystal molecules having a plane-symmetrical bend orientation |
| US6114133A (en) | 1994-11-14 | 2000-09-05 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) |
| US5688651A (en) | 1994-12-16 | 1997-11-18 | Ramot University Authority For Applied Research And Development Ltd. | Prevention of protein aggregation |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5786180A (en) | 1995-02-14 | 1998-07-28 | Bayer Corporation | Monoclonal antibody 369.2B specific for β A4 peptide |
| US6214966B1 (en) | 1996-09-26 | 2001-04-10 | Shearwater Corporation | Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution |
| US20040121415A1 (en) * | 1996-12-10 | 2004-06-24 | King David John | Monovalent antibody fragments |
| US6218506B1 (en) | 1997-02-05 | 2001-04-17 | Northwestern University | Amyloid β protein (globular assembly and uses thereof) |
| US6413940B1 (en) | 1997-02-07 | 2002-07-02 | Nymox Corporation | Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS |
| US20020086847A1 (en) | 1997-04-09 | 2002-07-04 | Mindset Biopharmaceuticals (Usa) | Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
| NZ337765A (en) | 1997-04-09 | 2001-09-28 | Mindset Biopharmaceuticals Usa | Recombinant antibodies having specificity for beta-amyloid N-terminus and C-terminus and use in treating Alzheimer's Disease |
| US6787319B2 (en) | 1997-04-16 | 2004-09-07 | American Home Products Corp. | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| US6227999B1 (en) | 1997-07-09 | 2001-05-08 | Transmisiones Tsp, S.A. De C.V. | Method and apparatus for operating a clutch in an automated mechanical transmission |
| IT1293511B1 (it) | 1997-07-30 | 1999-03-01 | Gentili Ist Spa | Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati |
| JP2001512689A (ja) | 1997-08-11 | 2001-08-28 | カイロン コーポレイション | Ｔ細胞を遺伝子改変するための方法 |
| US6448369B1 (en) | 1997-11-06 | 2002-09-10 | Shearwater Corporation | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| ES2222689T3 (es) | 1998-03-12 | 2005-02-01 | Nektar Therapeutics Al, Corporation | Derivados del polietilenglicol con grupos reactivos proximales. |
| DK1078005T3 (da) | 1998-05-21 | 2010-08-09 | Univ Tennessee Res Foundation | Fremgangsmåder til amyloidfjernelse ved anvendelse af anti-amyloidantistoffer |
| WO2000077178A1 (en) | 1999-06-16 | 2000-12-21 | Boston Biomedical Research Institute | IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO |
| ES2235926T3 (es) | 1999-08-04 | 2005-07-16 | The University Of Southern California | Ensamblaje globular de proteina beta amiloide y sus usos. |
| HK1044564B (en) | 1999-09-03 | 2010-05-28 | 拉莫特大学应用研究和工业开发有限公司 | Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease |
| US6294171B2 (en) | 1999-09-14 | 2001-09-25 | Milkhaus Laboratory, Inc. | Methods for treating disease states comprising administration of low levels of antibodies |
| DK1259562T3 (da) | 1999-12-22 | 2006-04-18 | Nektar Therapeutics Al Corp | Sterisk hindrede derivater af vandoplöselige polymerer |
| US6413507B1 (en) | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
| SI1257584T2 (sl) | 2000-02-24 | 2013-07-31 | Washington University St. Louis | Humanizirana protitelesa, ki veĹľejo amiloidni peptid beta |
| US20020009445A1 (en) | 2000-07-12 | 2002-01-24 | Yansheng Du | Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease |
| WO2002021141A2 (en) | 2000-09-06 | 2002-03-14 | Aventis Pharma S.A. | Methods and compositions for diseases associated with amyloidosis |
| US6436386B1 (en) | 2000-11-14 | 2002-08-20 | Shearwater Corporation | Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
| TWI255272B (en) | 2000-12-06 | 2006-05-21 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| US20040192898A1 (en) | 2001-08-17 | 2004-09-30 | Jia Audrey Yunhua | Anti-abeta antibodies |
| AU2002324468A1 (en) | 2001-08-17 | 2003-03-03 | Eli Lilly And Company | Rapid improvement of cognition in conditions related to abeta |
| ES2295401T3 (es) | 2001-08-17 | 2008-04-16 | Washington University | Metodo de ensayo para la enfermedad de alzheimer. |
| PT1944040E (pt) | 2001-08-17 | 2012-10-31 | Univ Washington | Método de avaliação para a doença de alzheimer |
| US20040241164A1 (en) | 2001-08-17 | 2004-12-02 | Bales Kelly Renee | Use of antibodies having high affinity for soluble ab to treat conditions and diseases related to ass |
| US7166478B2 (en) | 2002-03-12 | 2007-01-23 | Enzo Life Sciences, Inc., C/O Enzo Biochem, Inc. | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses |
| CA2483729A1 (en) | 2002-04-25 | 2003-11-06 | Eli Lilly And Company | Method for treating anxiety and mood disorders in older subjects |
| WO2004060965A2 (en) * | 2002-12-31 | 2004-07-22 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
| WO2004071408A2 (en) * | 2003-02-10 | 2004-08-26 | Applied Molecular Evolution, Inc. | Aβ BINDING MOLECULES |
| DK1639011T3 (da) * | 2003-06-30 | 2009-02-16 | Domantis Ltd | Pegylerede enkelt-domæne antistoffer (dAb) |
| BRPI0518151A2 (pt) * | 2004-10-13 | 2009-06-16 | Ablynx Nv | polipetìdeos contra amiloide-beta, ácido nucléico que codifica tal polipetìdeo, composição compreendendo tal polipetìdeo, método para produzir um polipetìdeo e uso do mesmo |
| EP1838349A1 (en) * | 2004-12-15 | 2007-10-03 | Neuralab, Ltd. | Amyloid beta antibodies for use in improving cognition |
-
2008
- 2008-01-09 KR KR1020097015076A patent/KR101160385B1/ko not_active Expired - Fee Related
- 2008-01-09 EA EA200970694A patent/EA020979B1/ru not_active IP Right Cessation
- 2008-01-09 LT LTEP14190162.9T patent/LT2842967T/lt unknown
- 2008-01-09 JP JP2009546461A patent/JP5307030B2/ja not_active Expired - Fee Related
- 2008-01-09 ES ES08713652.9T patent/ES2535641T3/es active Active
- 2008-01-09 CA CA2675847A patent/CA2675847C/en not_active Expired - Fee Related
- 2008-01-09 DK DK08713652.9T patent/DK2121754T3/en active
- 2008-01-09 CN CN201310412048.9A patent/CN103479998B/zh not_active Expired - Fee Related
- 2008-01-09 US US12/521,309 patent/US8066999B2/en not_active Expired - Fee Related
- 2008-01-09 BR BRPI0806715-5A patent/BRPI0806715A2/pt not_active IP Right Cessation
- 2008-01-09 PT PT141901629T patent/PT2842967T/pt unknown
- 2008-01-09 EP EP08713652.9A patent/EP2121754B1/en active Active
- 2008-01-09 RS RS20150252A patent/RS53948B1/sr unknown
- 2008-01-09 ES ES14190162.9T patent/ES2615454T3/es active Active
- 2008-01-09 SI SI200831733A patent/SI2842967T1/sl unknown
- 2008-01-09 MX MX2009007691A patent/MX2009007691A/es not_active Application Discontinuation
- 2008-01-09 HR HRP20150237AT patent/HRP20150237T1/hr unknown
- 2008-01-09 KR KR1020127003094A patent/KR101414847B1/ko not_active Expired - Fee Related
- 2008-01-09 PL PL08713652T patent/PL2121754T3/pl unknown
- 2008-01-09 CN CN2008800026216A patent/CN101981053B/zh not_active Expired - Fee Related
- 2008-01-09 PT PT87136529T patent/PT2121754E/pt unknown
- 2008-01-09 EP EP14190162.9A patent/EP2842967B1/en active Active
- 2008-01-09 UA UAA200907146A patent/UA95996C2/ru unknown
- 2008-01-09 AU AU2008206555A patent/AU2008206555B2/en not_active Ceased
- 2008-01-09 WO PCT/US2008/050554 patent/WO2008088983A1/en not_active Ceased
- 2008-01-09 SI SI200831378T patent/SI2121754T1/sl unknown
- 2008-01-11 TW TW097101232A patent/TW200836763A/zh unknown
- 2008-01-16 CL CL200800121A patent/CL2008000121A1/es unknown
- 2008-01-17 PE PE2008000153A patent/PE20081634A1/es not_active Application Discontinuation
- 2008-01-17 AR ARP080100214A patent/AR064944A1/es unknown
-
2009
- 2009-07-13 IL IL199838A patent/IL199838A/en not_active IP Right Cessation
-
2013
- 2013-06-26 JP JP2013133551A patent/JP5782479B2/ja not_active Expired - Fee Related
-
2014
- 2014-02-06 IL IL230876A patent/IL230876A/en not_active IP Right Cessation
-
2015
- 2015-03-31 CY CY20151100312T patent/CY1116157T1/el unknown
-
2016
- 2016-12-08 HR HRP20161677TT patent/HRP20161677T1/hr unknown
-
2017
- 2017-01-24 CY CY20171100108T patent/CY1118554T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522141A5 (enExample) | ||
| HRP20161677T1 (hr) | Pegilirani fab protiv amiloida beta | |
| HRP20170110T1 (hr) | Monoklonska protutijela | |
| EA201000809A1 (ru) | АНТИТЕЛА, СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ ПРОТОФИБРИЛЛЯРНОЙ ФОРМЫ БЕЛКА β-АМИЛОИДА | |
| RU2571204C3 (ru) | Специфические связывающие агенты против в7-н1 | |
| CY1113630T1 (el) | Αντισωματα αντι-χεπσιδινης και χρησεις εξ αυτωn | |
| HRP20160151T1 (hr) | PROTUTIJELA PROTIV N3pGlu-AMILOIDNOG BETA PEPTIDA I NJIHOVA UPOTREBA | |
| CY1120014T1 (el) | Αντισωματα συνδεσης πρωτοϊνιδιου και χρηση αυτων σε θεραπευτικες και διαγνωστικες μεθοδους για ασθενεια parkinson, ανοια με σωματα lewy και αλλες αλφα-συνουκλεϊνοπαθειες | |
| JP2013525266A5 (enExample) | ||
| IL319612A (en) | Antibody drug conjugates (ADC) that bind to 191P4D12 proteins | |
| HRP20200036T1 (hr) | Postupci liječenja tauopatije | |
| JP2019059786A5 (enExample) | ||
| RU2534564C3 (ru) | Мультиспецифическая связывающая антиген молекула, которая обладает альтернативной функцией к функции фактора свертывания крови viii | |
| JP2006522830A5 (enExample) | ||
| JP2013538796A5 (enExample) | ||
| UA116871C2 (uk) | СПОСІБ ЛІКУВАННЯ МІЄЛОДИСПЛАСТИЧНОГО СИНДРОМУ, ТАЛАСЕМІЇ ТА СЕРПОПОДІБНО-КЛІТИННОЇ АНЕМІЇ ЗА ДОПОМОГОЮ ЗАСТОСУВАННЯ АНТАГОНІСТА АКТИВІНУ ПОЛІПЕПТИДУ ActRII | |
| JP2010539921A5 (enExample) | ||
| RU2010119521A (ru) | Антитела, связывающие il-4 и/или il-13, и их применение | |
| JP2014508748A5 (enExample) | ||
| WO2006110214A3 (en) | Antibodies against mammalian metapneumovirus | |
| JP2006506942A5 (enExample) | ||
| JP2013535445A5 (enExample) | ||
| JP2010513327A5 (enExample) | ||
| CR20120491A (es) | Proteinas de unión a antigeno especificas para el componente amiloide serico p | |
| JP2007516193A5 (enExample) |